U.S. Scaffold Technology Market (2024 - 2030) Size, Share & Trends Analysis Report By Type (Hydrogels, Polymeric Scaffolds), By Disease Type (Skin & Integumentary, Dental, Cardiology & Vascular), By Application, By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Disease Type
                        1.2.3. Application
                        1.2.4. End-use
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Scaffold Technology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                    3.3. U.S. Scaffold Technology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. U.S. Scaffold Technology Market: Type Estimates & Trend Analysis
                    4.1. U.S. Scaffold Technology Market: Type Dashboard
                    4.2. U.S. Scaffold Technology Market: Type Movement Analysis
                    4.3. U.S. Scaffold Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Hydrogels
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Wound Healing
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. 3D Bioprinting
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Immunomodulation
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Polymeric Scaffolds
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Micropatterned Surface Microplates
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Nanofiber Based Scaffolds
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Scaffold Technology Market: Disease Type Estimates & Trend Analysis
                    5.1. U.S. Scaffold Technology Market: Disease Type Dashboard
                    5.2. U.S. Scaffold Technology Market: Disease Type Movement Analysis
                    5.3. U.S. Scaffold Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Orthopedics, Musculoskeletal, & Spine
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Cancer
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Skin & Integumentary
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Dental
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. Cardiology & Vascular
                        5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. Neurology
                        5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.10. Urology
                        5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.11. GI, Gynecology
                        5.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.12. Other Diseases
                        5.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Scaffold Technology Market: Application Estimates & Trend Analysis
                    6.1. U.S. Scaffold Technology Market: Application Dashboard
                    6.2. U.S. Scaffold Technology Market: Application Movement Analysis
                    6.3. U.S. Scaffold Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Drug Discovery
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Other Applications
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Scaffold Technology Market: End-use Estimates & Trend Analysis
                    7.1. U.S. Scaffold Technology Market: End-use Dashboard
                    7.2. U.S. Scaffold Technology Market: End-use Movement Analysis
                    7.3. U.S. Scaffold Technology Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    7.4. Biotechnology and Pharmaceutical Industries
                        7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.5. Research Laboratories and Institutes
                        7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Hospitals and Diagnostic Centers
                        7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. Other End-uses
                        7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. List of key distributors and channel partners
                        8.3.2. Key customers
                        8.3.3. Key company market share analysis, 2023
                        8.3.4. Thermo Fisher Scientific, Inc.
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Merck KGaA
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Tecan Trading AG
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. REPROCELL Inc.
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. 3D Biotek LLC
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Becton, Dickinson, and Company
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Medtronic
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Xanofi
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives
                        8.3.12. Molecular Matrix, Inc.
                            8.3.12.1. Company overview
                            8.3.12.2. Financial performance
                            8.3.12.3. Product benchmarking
                            8.3.12.4. Strategic initiatives
                        8.3.13. Pelobiotech
                            8.3.13.1. Company overview
                            8.3.13.2. Financial performance
                            8.3.13.3. Product benchmarking
                            8.3.13.4. Strategic initiatives
                        8.3.14. 4titude
                            8.3.14.1. Company overview
                            8.3.14.2. Financial performance
                            8.3.14.3. Product benchmarking
                            8.3.14.4. Strategic initiatives
                        8.3.15. Corning Incorporated
                            8.3.15.1. Company overview
                            8.3.15.2. Financial performance
                            8.3.15.3. Product benchmarking
                            8.3.15.4. Strategic initiatives
                        8.3.16. Akron Biotech
                            8.3.16.1. Company overview
                            8.3.16.2. Financial performance
                            8.3.16.3. Product benchmarking
                            8.3.16.4. Strategic initiatives
                        8.3.17. Avacta Life Sciences Limited.
                            8.3.17.1. Company overview
                            8.3.17.2. Financial performance
                            8.3.17.3. Product benchmarking
                            8.3.17.4. Strategic initiatives
                        8.3.18. Vericel Corporation
                            8.3.18.1. Company overview
                            8.3.18.2. Financial performance
                            8.3.18.3. Product benchmarking
                            8.3.18.4. Strategic initiatives
                        8.3.19. NuVasive, Inc.
                            8.3.19.1. Company overview
                            8.3.19.2. Financial performance
                            8.3.19.3. Product benchmarking
                            8.3.19.4. Strategic initiatives
                        8.3.20. Allergan
                            8.3.20.1. Company overview
                            8.3.20.2. Financial performance
                            8.3.20.3. Product benchmarking
                            8.3.20.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. scaffold technology market, 2018 - 2030 (USD Million)
Table 3 U.S. scaffold technology market, by type, 2018 - 2030 (USD Million)
Table 4 U.S. scaffold technology market, by disease type, 2018 - 2030 (USD Million)
Table 5 U.S. scaffold technology market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. scaffold technology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. scaffold technology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. scaffold technology market: Type outlook and key takeaways
Fig. 16 U.S. scaffold technology market: Type movement analysis
Fig. 17 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 U.S. scaffold technology market: Disease type outlook and key takeaways
Fig. 22 U.S. scaffold technology market: Type movement analysis
Fig. 23 Orthopedics, musculoskeletal, & spine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Skin & integumentary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Dental market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Cardiology & vascular market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Urology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 GI, gynecology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Other diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. scaffold technology market: Application outlook and key takeaways
Fig. 33 U.S. scaffold technology market: Application movement analysis
Fig. 34 Stem cell therapy, regenerative medicine, & tissue engineering market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 U.S. scaffold technology market: End-use outlook and key takeaways
Fig. 38 U.S. scaffold technology market: End-use movement analysis
Fig. 39 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Company market share analysis, 2023
Fig. 44 Strategic framework